Estrella Immunopharma Inc. Net Asset Momentum
Estrella Immunopharma Inc. net asset momentum. Estrella Immunopharma Inc. (ESLA) recorded a net asset momentum of -7312.1% as of December 2025, with net assets of $-10.37 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore ESLA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Estrella Immunopharma Inc. (2020–2025)
Net asset momentum of Estrella Immunopharma Inc. from 2020 to 2025. This chart tracks Estrella Immunopharma Inc.'s year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -7312.1%, with net assets of $-10.37 Million USD as of December 2025. See Estrella Immunopharma Inc. net assets for net asset value and shareholders' equity analysis.
Estrella Immunopharma Inc. Net Asset Momentum by Year (2020–2025)
Estrella Immunopharma Inc. net asset momentum by year from 2020 to 2025. The table below shows the complete annual net asset history for Estrella Immunopharma Inc. from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Estrella Immunopharma Inc. market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $-10.37 Million | $3.18 Million | $13.54 Million | ▼ -7312.1% |
| 2024 | $143.73K | $3.14 Million | $3.00 Million | ▼ -96.6% |
| 2023 | $4.27 Million | $4.45 Million | $180.70K | ▼ -39.6% |
| 2022 | $7.07 Million | $9.99 Million | $2.92 Million | ▲ +780.0% |
| 2021 | $-1.04 Million | $4.92 Million | $5.96 Million | — |
| 2020 | $0.00 | $0.00 | $0.00 | — |